Australia, Sept. 2 -- Telix Pharmaceuticals Ltd., owns the trademark (2516460) for 'RLS' till Jan. 23, 2035.
Status: registered:
Registered/protected
Classes: 5 [isotopes for medical purposes; radio-isotope markers for therapeutic or diagnostic use; chemical products for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations; none of the foregoing in relation to restless leg syndrome], 10 [diagnostic imaging apparatus for medical use; medical apparatus; systems comprising medical apparatus and accessories for administering measured doses of pharmaceutical preparations; applicators for pharmaceutical preparations; none of the foregoing in relation to restless leg syndrome], 35 [retail and wholesale services for pharmaceuticals, medical and veterinary preparations; retail services or wholesale services for medical apparatus; retail and wholesale services for radiopharmaceuticals for clinical and medical use; none of the foregoing in relation to restless leg syndrome], 39 [transportation of goods; transport and storage of chemicals; storage of pharmaceuticals], 40 [custom manufacture of pharmaceuticals; custom manufacture of pharmaceutical preparations; none of the foregoing in relation to restless leg syndrome] and 42 [calibration of medical apparatus; calibration of laboratory equipment; radiation measurement services; scientific and medical research and development; none of the foregoing in relation to restless leg syndrome]
Type of Mark: Word
Date of Acceptance: May 12
Registration Advertised: Sept. 1
For further details contact Herbert Smith Freehills Kramer.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2516460.
Disclaimer: Curated by HT Syndication.
